Qvar and Fabrazyme drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Qvar (beclomethasone dipropionate) and Fabrazyme (agalsidase beta). Common drug interactions include albumin urine present among females and pancreatitis among males.

The phase IV clinical study analyzes what interactions people have when they take Qvar and Fabrazyme. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Qvar?

Qvar has active ingredients of beclomethasone dipropionate. It is often used in asthma. eHealthMe is studying from 17,355 Qvar users. Check the latest studies of Qvar.

What is Fabrazyme?

Fabrazyme has active ingredients of agalsidase beta. eHealthMe is studying from 10,406 Fabrazyme users. Check the latest studies of Fabrazyme.



On Jul, 31, 2026

18 people who take Qvar and Fabrazyme together, and have interactions are studied.

Qvar and Fabrazyme drug interactions.

What are the common drug interactions of Qvar and Fabrazyme, by gender? *:

female:

  1. Albumin urine present
  2. Aphasia (damage to the parts of the brain that control language)
  3. Atrial flutter (an abnormal heart rhythm that occurs in the atria of the heart)
  4. Autoimmune thyroiditis (form of thyroiditis associated with an autoimmune disease)
  5. Blood albumin decreased
  6. Blood calcium decreased
  7. Blood chloride increased
  8. Blood urea decreased
  9. Carbon dioxide decreased
  10. Cerebral hypoperfusion (a condition in which the brain doesn't get enough blood)

male:

  1. Pancreatitis (inflammation of pancreas)
  2. Abdominal pain upper
  3. Pain
  4. Gastritis (inflammation of stomach)
  5. Muscle spasms (muscle contraction)
  6. Nausea (feeling of having an urge to vomit)
  7. Vomiting
  8. Tenderness (pain or discomfort when an affected area is touched)
  9. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  10. Pancreatitis relapsing

What are the common drug interactions of Qvar and Fabrazyme, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Abdominal pain upper

10-19:

  1. Pancreatitis (inflammation of pancreas)
  2. Pain
  3. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  4. Wisdom teeth removal

20-29:

  1. Abdominal pain upper
  2. Gastritis (inflammation of stomach)
  3. Muscle spasms (muscle contraction)
  4. Nausea (feeling of having an urge to vomit)
  5. Vomiting
  6. Pain
  7. Pancreatitis (inflammation of pancreas)
  8. Tenderness (pain or discomfort when an affected area is touched)
  9. Pancreatitis relapsing

30-39:

n/a

40-49:

  1. Blood urea decreased
  2. Carbon dioxide decreased
  3. Cerebral hypoperfusion (a condition in which the brain doesn't get enough blood)
  4. Cerebral infarction (less blood supply to brain resulting tissue damage)
  5. Cerebral ischaemia (insufficient blood flow to the brain to meet metabolic demand)
  6. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  7. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  8. Confusional state
  9. Congestive cardiomyopathy (weakening of heart muscle)
  10. Contusion (a type of hematoma of tissue in which capillaries)

50-59:

  1. Fall
  2. Memory impairment
  3. Nausea (feeling of having an urge to vomit)

60+:

n/a

What are the existing conditions these people have? *

  1. Fabry's Disease (build up of a particular type of fat, called globotriaosylceramide, in the body's cells): 18 people, 100.00%
  2. Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 5 people, 27.78%
  3. High Blood Pressure: 4 people, 22.22%
  4. Lipidosis (disorder of lipid metabolism involving abnormal accumulation of lipids in the reticuloendothelial cells): 3 people, 16.67%
  5. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 16.67%
  6. Hypersensitivity: 3 people, 16.67%
  7. Skin Blushing/flushing (a sudden reddening of the face, neck): 2 people, 11.11%
  8. Neuralgia (pain in one or more nerves): 1 person, 5.56%
  9. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Qvar and Fabrazyme?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Qvar and Fabrazyme:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Qvar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Fabrazyme:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Qvar and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Fabrazyme and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on beclomethasone dipropionate and agalsidase beta (the active ingredients of Qvar and Fabrazyme, respectively), and Qvar and Fabrazyme (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: